Key result
Accurate classification and multidisciplinary management involving pathology, surgery, and radiotherapy are critical for the initial treatment of soft tissue sarcomas.
Highlights the importance of accurate histomorphological and molecular classification, along with a multidisciplinary approach, in the initial management of soft tissue sarcomas.
Supports accurate classification and multidisciplinary care in soft tissue sarcomas; leaves open prospective validation of integrated protocols.
Soft tissue sarcomas are a heterogeneous group of rare malignancies. The diagnostic gold standard is conventional histomorphology with integrated immunohistochemistry. Molecular genetic profiling has identified new subgroups of undifferentiated sarcomas involving genetic rearrangements with creation of fusion genes. Accurate classification of sarcomas is critical for appropriate clinical decision-making which should involve a multidisciplinary team. A preoperative biopsy is necessary to confirm a diagnosis. Strategy is discussed in the multidisciplinary board. Reconstructive surgery must be planned in advance taking into account possible surgical morbidity. In high-risk situations, neo-adjuvant treatment could facilitate surgery in some cases, increase survival and provide indications of tumor biology. The decision is based on tumor subtype, grade and location, patient age and presence of comorbidities.
No takes yet. Share an insight, caveat, or question.
Tos et al. (2018) conducted a review in Soft tissue sarcoma. Pathology, surgery, and radiotherapy was evaluated. Accurate classification and multidisciplinary management involving pathology, surgery, and radiotherapy are critical for the initial treatment of soft tissue sarcomas.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: